Advertisement

Index by author

February 01, 2005; Volume 33,Issue 2

  1. Maggs, James L.

    1. FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY
      Jane R. Kenny, James L. Maggs, Justice N. A. Tettey, Andrew W. Harrell, Steven G. Parker, Stephen E. Clarke and B. Kevin Park
      Drug Metabolism and Disposition February 2005, 33 (2) 271-281; DOI: https://doi.org/10.1124/dmd.104.001677

  2. Ninomiya, Mizuki

    1. FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2
      Mizuki Ninomiya, Kousei Ito and Toshiharu Horie
      Drug Metabolism and Disposition February 2005, 33 (2) 225-232; DOI: https://doi.org/10.1124/dmd.104.002196

  3. Obach, R. Scott

    1. SERTRALINE IS METABOLIZED BY MULTIPLE CYTOCHROME P450 ENZYMES, MONOAMINE OXIDASES, AND GLUCURONYL TRANSFERASES IN HUMAN: AN IN VITRO STUDY
      R. Scott Obach, Loretta M. Cox and Larry M. Tremaine
      Drug Metabolism and Disposition February 2005, 33 (2) 262-270; DOI: https://doi.org/10.1124/dmd.104.002428

  4. Park, B. Kevin

    1. FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY
      Jane R. Kenny, James L. Maggs, Justice N. A. Tettey, Andrew W. Harrell, Steven G. Parker, Stephen E. Clarke and B. Kevin Park
      Drug Metabolism and Disposition February 2005, 33 (2) 271-281; DOI: https://doi.org/10.1124/dmd.104.001677

  5. Parker, Steven G.

    1. FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY
      Jane R. Kenny, James L. Maggs, Justice N. A. Tettey, Andrew W. Harrell, Steven G. Parker, Stephen E. Clarke and B. Kevin Park
      Drug Metabolism and Disposition February 2005, 33 (2) 271-281; DOI: https://doi.org/10.1124/dmd.104.001677

  6. Phillips, Anna

    1. IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION
      Anna Phillips, Steve R. Hood, G. Gordon Gibson and Nick J. Plant
      Drug Metabolism and Disposition February 2005, 33 (2) 233-242; DOI: https://doi.org/10.1124/dmd.104.001461

  7. Plant, Nick J.

    1. IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION
      Anna Phillips, Steve R. Hood, G. Gordon Gibson and Nick J. Plant
      Drug Metabolism and Disposition February 2005, 33 (2) 233-242; DOI: https://doi.org/10.1124/dmd.104.001461

  8. Pollack, Gary M.

    1. MULTIPLE TRANSPORT SYSTEMS MEDIATE THE HEPATIC UPTAKE AND BILIARY EXCRETION OF THE METABOLICALLY STABLE OPIOID PEPTIDE [d-PENICILLAMINE2,5]ENKEPHALIN
      Keith A. Hoffmaster, Maciej J. Zamek-Gliszczynski, Gary M. Pollack and Kim L. R. Brouwer
      Drug Metabolism and Disposition February 2005, 33 (2) 287-293; DOI: https://doi.org/10.1124/dmd.104.001420

  9. Prabhu, Saileta

    1. METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13
      Ziping Bao, Xiao-Yang He, Xinxin Ding, Saileta Prabhu and Jun-Yan Hong
      Drug Metabolism and Disposition February 2005, 33 (2) 258-261; DOI: https://doi.org/10.1124/dmd.104.002105

  10. Raghavan, Nirmala

    1. CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES
      Nirmala Raghavan, Donglu Zhang, Mingshe Zhu, Jianing Zeng and Lisa Christopher
      Drug Metabolism and Disposition February 2005, 33 (2) 203-208; DOI: https://doi.org/10.1124/dmd.104.001198
« Previous (Pages : 1 2 3 4 5 6 7 ... 7) Next »
Back to top

In this issue

Advertisement